Fig. 6

Quantification of serum HBV DNA and RNA levels, and proportion of HBV RNA in the O-glycosylated HBsAg-binding fraction in patients with undetectable HBV DNA after 48 weeks of nucleos(t)ide analog therapy. The bars in the scatter plots represent the median values. In the floating boxes, the box length represents the range and the horizontal line within the box represents the median value. Results at baseline and at 48 weeks were compared using Wilcoxon’s signed rank test. HBcrAg hepatitis B core-related antigen, HBsAg hepatitis B surface antigen, HBV hepatitis B virus, IP immunoprecipitate